Group proceeding brought on behalf of persons who were provided with cell-free non-invasive pre-implantation testing (nIPT-A testing) on their live embryos between May 2019 and October 2020 and suffered financial loss and psychiatric injury as a result.
The claim alleges that patients were provided the service of niPGT-A testing of their live embryos. Some patients had their embryos classified as abnormal and unsuitable for transfer as a result of this testing. The claim alleges that niPGT-A testing should not have been conducted because there was a substantial risk, not disclosed to patients, that it might produce false positive results and therefore an erroneous determination that an embryo was not suitable for transfer.
The deadline for opting out has now passed.
Please note that the deadline for opting out has now passed.
If you fall within the definition of a group member as set out in the Notice (a copy of which is below), you will remain a group member unless you took steps to opt-out before the deadline on Friday, 3 March 2023. The Notice contains important information about your rights to opt-out of the proceeding. If you are a group member, or think that you may be a group member, you should read the documents below carefully.
Defence of the first, second, third, fourth, fifth, sixth and eighth defendants filed 7 September 2022
Defence of the seventh defendant filed 19 August 2022
Amended Statement of Claim filed 6 June 2022
Group Proceeding Summary Statement filed on 4 March 2021.
Funding Information Summary Statement filed 23 December 2020